CL vs LFCR · P/E 34, rev $10.69B vs $207.1M cap
Colgate-Palmolive Company (CL) versus Lifecore Biomedical Inc. (LFCR) — a side-by-side from cached financials, not a winner call.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
Lifecore Biomedical Inc. (LFCR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported CL revenue for 2026-06-30 was $10.69B. Net income was $1.34B. CL currently screens at market cap $70.88B and trailing P/E 34.3.
LFCR does not have a complete income-statement cache yet.
CL currently screens at market cap $70.88B and trailing P/E 34.3. LFCR currently screens at market cap $207.1M.
Not investment advice. Open the CL and LFCR stock pages for the full models.
Not investment advice.